Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284319 · ClinicalTrials.gov registry record · NA
Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04284319: Completed NA study, sponsored by NYU Langone Health.
NCT04284319 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04284319, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart prior to final acceptance for transplantation without the imminent danger of ongoing warm ischemia.
Primary Outcome
The primary outcome is the rate of successful NRP-DCD heart transplants.
Interventions
- PROCEDURE DCD Heart Transplantation Using NRP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT04284319 record still lists
NCT04284319 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which DCD Heart Transplantation Using NRP is the first listed.
NCT04284319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04284319 about?
NCT04284319 is a clinical study titled "Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death". Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemody...
What is the current status of trial NCT04284319?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-20. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04284319?
The interventions under investigation include: DCD Heart Transplantation Using NRP (PROCEDURE).
Who is sponsoring clinical trial NCT04284319?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04284319's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI